ClinConnect ClinConnect Logo
Search / Trial NCT03956095

Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · May 17, 2019

Trial Information

Current as of May 07, 2025

Active, not recruiting

Keywords

Nutritional Supplement Shakes 19 108

ClinConnect Summary

This clinical trial is studying the use of nutritional supplement shakes for women who are about to have surgery to remove ovarian cancer. The goal is to see if a program that provides these shakes before surgery can help support the patients' nutrition and overall health during this important time. The study is currently active, but they are not recruiting new participants at the moment.

To be eligible for this study, participants need to be at least 18 years old and scheduled for a specific type of surgery called primary debulking surgery for ovarian, fallopian tube, or primary peritoneal cancer. They must also have enough time before their surgery to start the nutritional shakes, with the last shake taken one to two days before the operation. However, women who have had certain treatments like chemotherapy, have diabetes, or have specific allergies are not able to participate. If someone joins the study, they can expect to receive these nutritional shakes as part of their care leading up to surgery, which could help improve their health during this critical period.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18
  • Scheduled to undergo primary surgical debulking of ovarian, fallopian tube and primary peritoneal cancer
  • Have a sufficient preoperative window during which the intervention can occur, with the last day of supplementation at least one and no more than two days prior to surgery; scheduling of the procedure should not be delayed due to participation in this investigation
  • Exclusion Criteria:
  • Have received neoadjuvant chemotherapy
  • Debulking surgery scheduled less than 8 days from initial visit
  • Are scheduled for a minimally invasive procedure
  • Unable to tolerate oral intake or have gastrointestinal issues that would prevent or prohibit oral supplement consumption
  • Have diabetes mellitus
  • Have allergies to the Ensure Surgery Immunonutrition Shake supplement
  • Have galactosemia

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.

Locations

New York, New York, United States

Miami, Florida, United States

Harrison, New York, United States

Middletown, New Jersey, United States

Montvale, New Jersey, United States

Commack, New York, United States

Harrison, New York, United States

Basking Ridge, New Jersey, United States

Uniondale, New York, United States

Patients applied

0 patients applied

Trial Officials

Vance Broach, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials